Apellis Pharmaceuticals, Inc. (APLS)
41.12
+0.15
(+0.37%)
USD |
NASDAQ |
May 06, 16:00
41.06
-0.06
(-0.15%)
Pre-Market: 20:00
Apellis Pharmaceuticals Free Cash Flow : 45.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.316B |
| Eli Lilly & Co. | 10.37B |
| Agios Pharmaceuticals, Inc. | -384.73M |
| Scholar Rock Holding Corp. | -300.64M |
| Kezar Life Sciences, Inc. | -51.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.18M |
| Cash from Investing (Quarterly) | -0.108M |
| Cash from Financing (Quarterly) | 1.259M |
| Free Cash Flow Per Share (Quarterly) | -0.1128 |
| Free Cash Flow to Equity (Quarterly) | -13.27M |
| Free Cash Flow to Firm (Quarterly) | -3.379M |
| Free Cash Flow Yield | 0.86% |